Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TADDP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
H1H7841N-7
|
|||||
| Synonyms |
H1H7841N-7
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.7
|
|||||
| Antibody Name |
H1H7841N
|
Antibody Info | ||||
| Antigen Name |
Metalloreductase STEAP2 (STEAP2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Cysteine-maleimide conjugation
|
|||||
| Combination Type |
Maytansin-3-N-methyl-L- (S)-alanine-propanamidyl-3-N-methyl-N-[4- (amino-citrulline-valine-hexanamide-6-maleimidy)benzyl]carbamate
|
|||||